Study Title: A Randomized Phase III Clinical Trial For The Addition Of Docetaxel To Androgen Receptor Pathway Inhibitors In Patients With Metastatic Castration Sensitive Prostate Cancer And Suboptimal PSA Response (TRIPLE-SWITCH)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Becker, Kevin, at beckerke@musc.edu.Study Coordinator, Tucker, Renee, at tuckerr@musc.edu.Trial opened at the following institutions: Medical University of South Carolina